7:31 am Amicus Therapeutics highlights data – encouraging additional post-hoc analyses of interim data from Phase 3 Fabry Monotherapy Study 011

more

View todays social media effects on FOLD

View the latest stocks trending across Twitter. Click to view dashboard

See who Amicus is hiring next, click here to view